NCT02479412 / 2014-005306-37: A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma |
|
|
| Completed | 2 | 54 | Europe | 800 μg AZD7594 once daily, High dose of AZD7594, 250 µg AZD7594 once daily, Medium dose of AZD7594, 58 µg AZD7594 once daily, Low dose of AZD7594, Placebo once daily, Placebo, Salbutamol, Rescue medication | AstraZeneca | Asthma, Efficacy, Safety | 02/16 | 02/16 | | |
